...
首页> 外文期刊>Pharmacogenetics and genomics >Mitochondrial tRNAThr G15927A mutation may modulate the phenotypic manifestation of ototoxic 12S rRNA A1555G mutation in four Chinese families.
【24h】

Mitochondrial tRNAThr G15927A mutation may modulate the phenotypic manifestation of ototoxic 12S rRNA A1555G mutation in four Chinese families.

机译:线粒体tRNAThr G15927A突变可能会调节四个中国家庭的耳毒性12S rRNA A1555G突变的表型表现。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

OBJECTIVE: To investigate the role of mitochondrial modifiers in the development of deafness associated with 12S rRNA A1555G mutation. METHODS: Four Chinese families with nonsyndromic and aminoglycoside-induced deafness were studied by clinical and genetic evaluation, molecular and biochemical analyses of mitochondrial DNA (mtDNA). RESULTS: These families exhibited high penetrance and expressivity of hearing impairment. Penetrances of hearing loss in WZD31, WZD32, WZD33, and WZD34 pedigrees ranged from 50 to 67% and from 39 to 50%, respectively, when aminoglycoside-induced hearing loss was included or excluded. Matrilineal relatives in these families developed hearing loss at the average of 14, 13, 16, and 15 years of age, respectively, when aminoglycoside-induced deafness was excluded. Mutational analysis of entire mtDNA in these families showed the homoplasmic A1555G mutation and distinct sets of variants belonging to haplogroup B5b1. Of these, the tRNA G15927A mutation locates at the fourth base in the anticodon stem (conventional position 42) of tRNA. A guanine (G42) at this position of tRNA is highly conserved from bacteria to human mitochondria. The lower levels and altered electrophoretic mobility of tRNA were observed in cells carrying A1555G and G15927A mutations or only G15927A mutation but not cells carrying only A1555G mutation. The abolished base pairing (28C-42G) of this tRNA by the G15927A mutation caused a failure in tRNA metabolism, worsening the mitochondrial dysfunctions altered by the A1555G mutation. CONCLUSION: The G15927A mutation has a potential modifier role in increasing the penetrance and expressivity of the deafness-associated 12S rRNA A1555G mutation in those Chinese pedigrees.
机译:目的:探讨线粒体修饰剂在与12S rRNA A1555G突变相关的耳聋发展中的作用。方法:通过临床和遗传学评估,线粒体DNA(mtDNA)的分子和生化分析,研究了四个非综合征性和氨基糖苷性耳聋的中国家庭。结果:这些家庭表现出较高的外露能力和听力障碍表现力。当包括或排除氨基糖苷类引起的听力损失时,WZD31,WZD32,WZD33和WZD34谱系的听力损失渗透率分别为50%至67%和39%至50%。当排除氨基糖苷类引起的耳聋时,这些家庭的母系亲属平均分别在14、13、16和15岁时出现听力下降。这些家族中整个mtDNA的突变分析显示同质A1555G突变和属于单倍型B5b1的不同变体集。其中,tRNA G15927A突变位于tRNA的反密码子茎的第4个碱基(常规位置42)。在tRNA此位置的鸟嘌呤(G42)从细菌到人类线粒体高度保守。在携带A1555G和G15927A突变或仅携带G15927A突变的细胞中观察到tRNA的水平较低,并且电泳迁移率发生了变化,但仅携带A1555G突变的细胞未见到。 G15927A突变消除了该tRNA的碱基配对(28C-42G),导致tRNA代谢失败,加剧了由A1555G突变改变的线粒体功能障碍。结论:G15927A突变可能在中国家系中增加与耳聋相关的12S rRNA A1555G突变的渗透性和表达能力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号